Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 18% ± 3% | |
vein endothelial cell | 5 studies | 31% ± 15% | |
endothelial cell of artery | 4 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of PLA1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 759.83 | 240 / 245 | 96% | 84.81 | 484 / 502 |
kidney | 100% | 592.63 | 89 / 89 | 94% | 67.01 | 850 / 901 |
liver | 100% | 1241.36 | 226 / 226 | 85% | 41.63 | 347 / 406 |
pancreas | 72% | 121.48 | 237 / 328 | 75% | 13.71 | 134 / 178 |
lung | 100% | 1878.96 | 578 / 578 | 37% | 7.48 | 428 / 1155 |
stomach | 85% | 259.01 | 304 / 359 | 51% | 9.60 | 147 / 286 |
thymus | 100% | 655.13 | 652 / 653 | 27% | 3.54 | 162 / 605 |
uterus | 96% | 392.41 | 163 / 170 | 25% | 6.42 | 113 / 459 |
breast | 87% | 291.75 | 399 / 459 | 26% | 4.22 | 292 / 1118 |
intestine | 66% | 181.04 | 642 / 966 | 38% | 6.36 | 199 / 527 |
eye | 0% | 0 | 0 / 0 | 98% | 137.23 | 78 / 80 |
skin | 13% | 21.92 | 240 / 1809 | 81% | 225.26 | 384 / 472 |
adipose | 94% | 383.73 | 1132 / 1204 | 0% | 0 | 0 / 0 |
muscle | 92% | 941.20 | 741 / 803 | 0% | 0 | 0 / 0 |
heart | 85% | 220.97 | 735 / 861 | 0% | 0 | 0 / 0 |
brain | 72% | 358.11 | 1907 / 2642 | 4% | 0.45 | 27 / 705 |
lymph node | 0% | 0 | 0 / 0 | 76% | 16.75 | 22 / 29 |
bladder | 48% | 78.19 | 10 / 21 | 27% | 4.47 | 134 / 504 |
blood vessel | 66% | 183.85 | 882 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 42% | 76.85 | 600 / 1445 | 16% | 2.93 | 29 / 183 |
ovary | 37% | 74.45 | 67 / 180 | 9% | 3.15 | 40 / 430 |
adrenal gland | 14% | 18.90 | 37 / 258 | 9% | 1.80 | 21 / 230 |
tonsil | 0% | 0 | 0 / 0 | 22% | 2.60 | 10 / 45 |
peripheral blood | 20% | 749.40 | 188 / 929 | 0% | 0 | 0 / 0 |
spleen | 19% | 32.00 | 46 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0036150 | Biological process | phosphatidylserine acyl-chain remodeling |
GO_0006629 | Biological process | lipid metabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0006658 | Biological process | phosphatidylserine metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0002080 | Cellular component | acrosomal membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0052739 | Molecular function | phosphatidylserine 1-acylhydrolase activity |
Gene name | PLA1A |
Protein name | Phospholipase A1 member A (EC 3.1.1.111) (Phosphatidylserine-specific phospholipase A1) (PS-PLA1) Phospholipase A1 member A (EC 3.1.1.111) |
Synonyms | NMD PSPLA1 hCG_22568 |
Description | FUNCTION: Hydrolyzes the ester bond of the acyl group attached at the sn-1 position of phosphatidylserines (phospholipase A1 activity) and 1-acyl-2-lysophosphatidylserines (lysophospholipase activity) in the pathway of phosphatidylserines acyl chain remodeling . Cleaves phosphatidylserines exposed on the outer leaflet of the plasma membrane of apoptotic cells producing 2-acyl-1-lysophosphatidylserines, which in turn enhance mast cell activation and histamine production (By similarity). Has no activity toward other glycerophospholipids including phosphatidylcholines, phosphatidylethanolamines, phosphatidic acids or phosphatidylinositols, or glycerolipids such as triolein (By similarity). .; FUNCTION: [Isoform 2]: Hydrolyzes lyso-PS but not PS. . |
Accessions | ENST00000494440.5 ENST00000475963.1 ENST00000273371.9 [Q53H76-1] ENST00000488919.5 [Q53H76-4] ENST00000495992.5 [Q53H76-3] H7C4H1 Q53H76 G5E9W0 |